Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework

Journal of Analytical Toxicology

Volumn 36, Issue 3, 2012, Pages 145-152

  Shanks, Kevin G ^a   Dahn, Tim ^a   Terrell, Andrea R ^a  

^a AIT Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID DERIVATIVE; ETHER; JWH 073; UNCLASSIFIED DRUG; 1 PENTYL 3 (1 NAPHTHOYL)INDOLE; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; INDOLE DERIVATIVE; JWH-073; NAPHTHALENE DERIVATIVE;

ACCURACY; ARTICLE; AUTOPSY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FORENSIC TOXICOLOGY; LIMIT OF DETECTION; LIQUID LIQUID EXTRACTION; PH; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADULT; BLOOD; CANNABIS ADDICTION; CASE REPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SUBSTANCE ABUSE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FORENSIC TOXICOLOGY; HUMANS; INDOLES; MALE; MARIJUANA ABUSE; MIDDLE AGED; NAPHTHALENES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84862167879     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks013     Document Type: Article

References (19)

1. Huffman, J.W., Dai, D. (1994) Design, synthesis and pharmacology of cannabimimetic indoles. Bioorganic and Medicinal Chemistry Letters, 4, 563-566.
2. Wiley, J.L., Compton, D.R., Dai, D., Lainton, J.A.H., Phillips, M., Huffman, J.W. et al. (1998) Structure-activity relationships of indole- and pyrrole-derived cannabinoids. Journal of Pharmacology and Experimental Therapeutics, 285, 995-1004.
3. Huffman, J.W., Padgett, L.W., Isherwood, M.L., Wiley, J.L., Martin, B.R. (2006) 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic and Medicinal Chemistry Letters, 16, 5432-5435.
4. Huffman, J.W., Mabon, R., Wu, M.-J., Lu, J., Hart, R., Hurst, D.P. et al. (2003) 3-Indolyl-1-naphthylmethanes: New cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor. Bioorganic and Medicinal Chemistry Letters, 11, 539-549.
5. Aung, M.M., Griffin, G., Huffman, J.W., Wu, M.-J., Keel, C., Yang, B. et al. (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug and Alcohol Dependence, 60, 133-140.
6. Atwood, B.K., Huffman, J.W., Straiker, A., Mackie, K. (2010) JWH-018, a common constituent of "spice" herbal blends, is a potent and efficacious cannabinoid receptor agonist. British Journal of Pharmacology, 160, 585-593.
7. Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Putz, M., Ferreiros, N. (2009) "Spice" and other herbal blends: Harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832-837.
8. Simmons, J., Cookman, L., Kang, C., Skinner, C. (2011) Three cases of "spice" exposure. Clinical Toxicology, 49, 431-433.
9. Every-Palmer, S. (2010) Warning: Legal synthetic cannabinoidreceptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction, 105, 1859-1861.
10. Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Goda, Y. (2009) Identification of a cannabinomimetic indole as a designer drug in a herbal product. Forensic Toxicology, 27, 61-66.
11. Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y. (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicology, 29, 25-37.
12. Dresen, S., Ferreiros, N., Putz, M., Westphal, F., Zimmermann, R., Auwarter, V. (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectrometry, 45, 1186-1194.
13. Beuerle, T., Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L. (2009) Spice: A never ending story? Forensic Science International, 191, 58-63.
14. Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P.I. et al. (2010) Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. Journal of Analytical Toxicology, 34, 252-260.
15. Penn, H.J., Langman, L.J., Unold, D., Shields, J., Nichols, J.H. (2011) Detection of synthetic cannabinoids in herbal incense products. Clinical Biochemistry, 44, 1163-1165.
16. Leonhart, M. Schedules of controlled substances: temporary placement of five synthetic cannabinoids into schedule I. US DOJ, DEA, 21 CFR Part 1308. Docket No. DEA-345F. March 1, 2011.
17. Teske, J., Weller, J.P., Fieguth, A., Rothamel, T., Schulz, Y., Troger, H.D. (2010) Sensitive and rapid quantification of cannabinoid receptor agonist napthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 878, 2659-2663.
18. Dresen, S., Kneisel, S., Weinmann, W., Zimmermann, R., Auwarter, V. (2011) Development and validation of a liquid chromatographytandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. Journal of Mass Spectrometry, 46, 163-171.
19. Kacinko, S.L., Xu, A., Homan, J.W., McMullin, M., Warrington, D.M., Logan, B. (2011) Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. Journal of Analytical Toxicology, 35, 386-393.